Mutational drivers of cancer cell migration and invasion

NM Novikov, SY Zolotaryova, AM Gautreau… - British journal of …, 2021 - nature.com
Genomic instability and mutations underlie the hallmarks of cancer—genetic alterations
determine cancer cell fate by affecting cell proliferation, apoptosis and immune response …

Transforming growth factor-beta (TGF-β) in prostate cancer: A dual function mediator?

S Mirzaei, MDA Paskeh, Y Saghari, A Zarrabi… - International Journal of …, 2022 - Elsevier
Transforming growth factor-beta (TGF-β) is a member of a family of secreted cytokines with
vital biological functions in cells. The abnormal expression of TGF-β signaling is a common …

Overexpression of lncRNA ANRIL promoted the proliferation and migration of prostate cancer cells via regulating let-7a/TGF-β1/Smad signaling pathway

B Zhao, YL Lu, Y Yang, LB Hu, Y Bai, RQ Li… - Cancer …, 2018 - content.iospress.com
Long non-coding RNAs (lncRNAs) were playing critical roles in tumorigenesis. However, in
prostate cancer, the roles and mechanisms of lncRNAs especially ANRIL were largely …

Infection by high-risk human papillomaviruses, epithelial-to-mesenchymal transition and squamous pre-malignant or malignant lesions of the uterine cervix: a series of …

G Barillari, R Bei, V Manzari, A Modesti - International journal of molecular …, 2021 - mdpi.com
Wound healing requires static epithelial cells to gradually assume a mobile phenotype
through a multi-step process termed epithelial-to-mesenchymal transition (EMT). Although it …

Current perspectives on inhibitory SMAD7 in health and disease

C de Ceuninck van Capelle, M Spit… - Critical Reviews in …, 2020 - Taylor & Francis
Transforming growth factor β (TGF-β) family members play an extensive role in cellular
communication that orchestrates both early development and adult tissue homeostasis …

High expression of hnRNPA1 promotes cell invasion by inducing EMT in gastric cancer

Y Chen, J Liu, W Wang, L Xiang… - Oncology …, 2018 - spandidos-publications.com
Advanced gastric cancer (GC) has a poor prognosis and its treatment strategies are not very
efficient. Heterogeneous nuclear ribonucleoprotein A1 (hnRNPA1) has emerged as a …

Past, current, and future strategies to target ERG fusion-positive prostate cancer

F Lorenzin, F Demichelis - Cancers, 2022 - mdpi.com
Simple Summary In addition to its role in development and in the vascular and
hematopoietic systems, ERG plays a central role in prostate cancer. Approximately 40–50 …

Long Noncoding RNA ANRIL as a Novel Biomarker in Human Cancer

N Lou, G Liu, Y Pan - Future Oncology, 2020 - Taylor & Francis
The long noncoding RNA ANRIL, located in the human chromosome 9p21 region, has been
reported to be involved in tumor progression. ANRIL regulates gene expression via …

Ras and Wnt interaction contribute in prostate cancer bone metastasis

SR Lin, N Mokgautsi, YN Liu - Molecules, 2020 - mdpi.com
Prostate cancer (PCa) is one of the most prevalent and malignant cancer types in men,
which causes more than three-hundred thousand cancer death each year. At late stage of …

Genome-based classification and therapy of prostate cancer

AK Angeles, S Bauer, L Ratz, SM Klauck, H Sültmann - Diagnostics, 2018 - mdpi.com
In the past decade, multi-national and multi-center efforts were launched to sequence
prostate cancer genomes, transcriptomes, and epigenomes with the aim of discovering the …